Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B

por Rogers, Geoffrey L, Martino, Ashley T, Zolotukhin, Irene, Ertl, Hildegund CJ, Herzog, Roland W
Publicado 2014

Innate Immune Responses to AAV Vectors

por Rogers, Geoffrey L., Martino, Ashley T., Aslanidi, George V., Jayandharan, Giridhara R., Srivastava, Arun, Herzog, Roland W.
Publicado 2011

Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes

por Rogers, Geoffrey L., Huang, Chun, Clark, Robert D.E., Seclén, Eduardo, Chen, Hsu-Yu, Cannon, Paula M.
Publicado 2021

Reprogramming human B cells with custom heavy chain antibodies

por Rogers, Geoffrey L., Huang, Chun, Mathur, Atishay, Huang, Xiaoli, Chen, Hsu-Yu, Stanten, Kalya, Morales, Heidy, Chang, Chan-Hua, Kezirian, Eric J., Cannon, Paula M.
Publicado 2023

Reprogramming human B cells with custom heavy chain antibodies

por Rogers, Geoffrey L., Huang, Chun, Mathur, Atishay, Huang, Xiaoli, Chen, Hsu-Yu, Stanten, Kalya, Morales, Heidy, Chang, Chan-Hua, Kezirian, Eric J., Cannon, Paula M.
Publicado 2023

Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation

por Chen, Hsu-Yu, Huang, Chun, Tian, Lu, Huang, Xiaoli, Zhang, Chennan, Llewellyn, George N., Rogers, Geoffrey L., Andresen, Kevin, O’Gorman, Maurice R. G., Chen, Ya-Wen, Cannon, Paula M.
Publicado 2021